Rare Disease Drugs Pose Major Challenge For Brazil, Says ANVISA’s New Chief

 
• By Francesca Bruce
  
New chief starts work at Brazil's medicines regulatory agency. (Shutterstock)

More from Agency Leadership

More from Latin America